

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | collagen fibril organization (GO:0030199) | 4.57549120 |
| 2 | endocardial cushion development (GO:0003197) | 4.33125008 |
| 3 | sequestering of extracellular ligand from receptor (GO:0035581) | 4.22955155 |
| 4 | cell migration involved in heart development (GO:0060973) | 4.21122301 |
| 5 | sulfur amino acid catabolic process (GO:0000098) | 4.10293881 |
| 6 | extracellular fibril organization (GO:0043206) | 4.01933899 |
| 7 | endodermal cell differentiation (GO:0035987) | 3.99228796 |
| 8 | complement activation, alternative pathway (GO:0006957) | 3.98716597 |
| 9 | alpha-linolenic acid metabolic process (GO:0036109) | 3.97752448 |
| 10 | glomerular basement membrane development (GO:0032836) | 3.96355751 |
| 11 | cGMP-mediated signaling (GO:0019934) | 3.89761125 |
| 12 | glomerular visceral epithelial cell development (GO:0072015) | 3.87013152 |
| 13 | bone trabecula formation (GO:0060346) | 3.79511007 |
| 14 | skin morphogenesis (GO:0043589) | 3.77659332 |
| 15 | mesenchymal-epithelial cell signaling (GO:0060638) | 3.75590308 |
| 16 | chondrocyte proliferation (GO:0035988) | 3.75460558 |
| 17 | kidney mesenchyme development (GO:0072074) | 3.74441124 |
| 18 | type B pancreatic cell proliferation (GO:0044342) | 3.68343677 |
| 19 | regulation of protein activation cascade (GO:2000257) | 3.67208351 |
| 20 | regulation of complement activation (GO:0030449) | 3.66449965 |
| 21 | metanephric mesenchyme development (GO:0072075) | 3.61468342 |
| 22 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.57879756 |
| 23 | lung vasculature development (GO:0060426) | 3.56360030 |
| 24 | negative regulation of smooth muscle cell migration (GO:0014912) | 3.55122135 |
| 25 | fibril organization (GO:0097435) | 3.50703939 |
| 26 | cell-substrate junction assembly (GO:0007044) | 3.47527730 |
| 27 | cellular response to vitamin (GO:0071295) | 3.42688377 |
| 28 | smooth muscle tissue development (GO:0048745) | 3.40937885 |
| 29 | fibroblast migration (GO:0010761) | 3.39531561 |
| 30 | L-phenylalanine catabolic process (GO:0006559) | 3.39173603 |
| 31 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.39173603 |
| 32 | glomerular epithelial cell development (GO:0072310) | 3.37883243 |
| 33 | cell adhesion mediated by integrin (GO:0033627) | 3.36793287 |
| 34 | pericardium development (GO:0060039) | 3.32277643 |
| 35 | basement membrane organization (GO:0071711) | 3.32161936 |
| 36 | valine metabolic process (GO:0006573) | 3.29497356 |
| 37 | adhesion of symbiont to host cell (GO:0044650) | 3.29369602 |
| 38 | virion attachment to host cell (GO:0019062) | 3.29369602 |
| 39 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.26430382 |
| 40 | protein carboxylation (GO:0018214) | 3.26430382 |
| 41 | collagen metabolic process (GO:0032963) | 3.25432830 |
| 42 | glomerulus development (GO:0032835) | 3.23386144 |
| 43 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.22967748 |
| 44 | L-phenylalanine metabolic process (GO:0006558) | 3.22967748 |
| 45 | mesodermal cell differentiation (GO:0048333) | 3.22270708 |
| 46 | renal filtration (GO:0097205) | 3.15632977 |
| 47 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 3.15249930 |
| 48 | drug transmembrane transport (GO:0006855) | 3.14988058 |
| 49 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.14342466 |
| 50 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.13299186 |
| 51 | cysteine metabolic process (GO:0006534) | 3.12500449 |
| 52 | actin filament depolymerization (GO:0030042) | 3.11948653 |
| 53 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.09602743 |
| 54 | negative regulation of fatty acid transport (GO:2000192) | 3.08912808 |
| 55 | collagen catabolic process (GO:0030574) | 3.08774684 |
| 56 | transcytosis (GO:0045056) | 3.05534455 |
| 57 | multicellular organismal macromolecule metabolic process (GO:0044259) | 3.04611105 |
| 58 | substrate adhesion-dependent cell spreading (GO:0034446) | 3.04439327 |
| 59 | homocysteine metabolic process (GO:0050667) | 3.03510340 |
| 60 | relaxation of smooth muscle (GO:0044557) | 2.99257872 |
| 61 | extracellular matrix assembly (GO:0085029) | 2.99046556 |
| 62 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.98055053 |
| 63 | midgut development (GO:0007494) | 2.97867231 |
| 64 | glomerular filtration (GO:0003094) | 2.97553263 |
| 65 | apoptotic cell clearance (GO:0043277) | 2.93702851 |
| 66 | positive regulation of fibroblast migration (GO:0010763) | 2.92915186 |
| 67 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 2.92321451 |
| 68 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.90875671 |
| 69 | negative regulation of fibrinolysis (GO:0051918) | 2.90836225 |
| 70 | protein heterotrimerization (GO:0070208) | 2.90388499 |
| 71 | adherens junction assembly (GO:0034333) | 2.90189976 |
| 72 | platelet aggregation (GO:0070527) | 2.89894984 |
| 73 | multicellular organismal metabolic process (GO:0044236) | 2.89549805 |
| 74 | protein localization to cell surface (GO:0034394) | 2.89487677 |
| 75 | regulation of cholesterol homeostasis (GO:2000188) | 2.89097607 |
| 76 | low-density lipoprotein particle clearance (GO:0034383) | 2.88026696 |
| 77 | lysine metabolic process (GO:0006553) | 2.87443594 |
| 78 | lysine catabolic process (GO:0006554) | 2.87443594 |
| 79 | aromatic amino acid family catabolic process (GO:0009074) | 2.87195395 |
| 80 | ethanol oxidation (GO:0006069) | 2.86535922 |
| 81 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.85266802 |
| 82 | extracellular matrix disassembly (GO:0022617) | 2.85192488 |
| 83 | multicellular organismal catabolic process (GO:0044243) | 2.85043264 |
| 84 | bile acid and bile salt transport (GO:0015721) | 2.84295752 |
| 85 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.84038766 |
| 86 | cellular response to vitamin D (GO:0071305) | 2.83607307 |
| 87 | positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511) | 2.83185821 |
| 88 | cell-substrate adherens junction assembly (GO:0007045) | 2.83119079 |
| 89 | focal adhesion assembly (GO:0048041) | 2.83119079 |
| 90 | barbed-end actin filament capping (GO:0051016) | 2.82011533 |
| 91 | regulation of triglyceride catabolic process (GO:0010896) | 2.81980390 |
| 92 | dermatan sulfate biosynthetic process (GO:0030208) | 2.81575778 |
| 93 | dermatan sulfate metabolic process (GO:0030205) | 2.80943797 |
| 94 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 2.80752566 |
| 95 | substrate-dependent cell migration (GO:0006929) | 2.80632806 |
| 96 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.80517531 |
| 97 | high-density lipoprotein particle remodeling (GO:0034375) | 2.80348351 |
| 98 | negative regulation of protein localization to cell surface (GO:2000009) | 2.79895597 |
| 99 | positive regulation of fatty acid oxidation (GO:0046321) | 2.78065809 |
| 100 | glyoxylate metabolic process (GO:0046487) | 2.77447433 |
| 101 | reverse cholesterol transport (GO:0043691) | 2.76818839 |
| 102 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.75378814 |
| 103 | adhesion of symbiont to host (GO:0044406) | 2.74633816 |
| 104 | stress fiber assembly (GO:0043149) | 2.74483626 |
| 105 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.73801132 |
| 106 | phospholipid homeostasis (GO:0055091) | 2.72182927 |
| 107 | urea cycle (GO:0000050) | 2.72085056 |
| 108 | urea metabolic process (GO:0019627) | 2.72085056 |
| 109 | extracellular matrix organization (GO:0030198) | 2.71624327 |
| 110 | epoxygenase P450 pathway (GO:0019373) | 2.71213080 |
| 111 | bile acid biosynthetic process (GO:0006699) | 2.70838676 |
| 112 | extracellular structure organization (GO:0043062) | 2.70640929 |
| 113 | growth hormone receptor signaling pathway (GO:0060396) | 2.70479153 |
| 114 | positive regulation of receptor recycling (GO:0001921) | 2.70476911 |
| 115 | fatty acid transmembrane transport (GO:1902001) | 2.68445300 |
| 116 | blood vessel maturation (GO:0001955) | 2.67538630 |
| 117 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.65879746 |
| 118 | urate metabolic process (GO:0046415) | 2.65780182 |
| 119 | regulation of fibrinolysis (GO:0051917) | 2.64431878 |
| 120 | plasma lipoprotein particle clearance (GO:0034381) | 2.63933810 |
| 121 | muscle cell migration (GO:0014812) | 2.62629910 |
| 122 | kynurenine metabolic process (GO:0070189) | 2.62614500 |
| 123 | respiratory tube development (GO:0030323) | 2.62496757 |
| 124 | hormone catabolic process (GO:0042447) | 2.61490963 |
| 125 | drug catabolic process (GO:0042737) | 2.61435999 |
| 126 | positive regulation of osteoblast proliferation (GO:0033690) | 2.61419874 |
| 127 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.60777052 |
| 128 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.60567705 |
| 129 | triglyceride homeostasis (GO:0070328) | 2.59681843 |
| 130 | acylglycerol homeostasis (GO:0055090) | 2.59681843 |
| 131 | bile acid metabolic process (GO:0008206) | 2.58219108 |
| 132 | hemidesmosome assembly (GO:0031581) | 2.57810995 |
| 133 | surfactant homeostasis (GO:0043129) | 2.57683524 |
| 134 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.57651112 |
| 135 | urinary tract smooth muscle contraction (GO:0014848) | 2.56933205 |
| 136 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.56772673 |
| 137 | indolalkylamine catabolic process (GO:0046218) | 2.55931962 |
| 138 | tryptophan catabolic process (GO:0006569) | 2.55931962 |
| 139 | indole-containing compound catabolic process (GO:0042436) | 2.55931962 |
| 140 | regulation of smooth muscle cell migration (GO:0014910) | 2.55877253 |
| 141 | fatty acid beta-oxidation (GO:0006635) | 2.55429149 |
| 142 | positive regulation of lipid catabolic process (GO:0050996) | 2.55137984 |
| 143 | endocrine hormone secretion (GO:0060986) | 2.55058082 |
| 144 | negative regulation of osteoblast proliferation (GO:0033689) | 2.54813713 |
| 145 | regulation of extracellular matrix disassembly (GO:0010715) | 2.54391680 |
| 146 | negative regulation of protein activation cascade (GO:2000258) | 2.54243630 |
| 147 | import into cell (GO:0098657) | 2.54157285 |
| 148 | endothelial cell morphogenesis (GO:0001886) | 2.53612378 |
| 149 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.53478305 |
| 150 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 2.53090094 |
| 151 | amino-acid betaine metabolic process (GO:0006577) | 2.52900297 |
| 152 | extracellular negative regulation of signal transduction (GO:1900116) | 2.52271096 |
| 153 | extracellular regulation of signal transduction (GO:1900115) | 2.52271096 |
| 154 | lymph vessel development (GO:0001945) | 2.48911349 |
| 155 | heme transport (GO:0015886) | 2.48656085 |
| 156 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.48234582 |
| 157 | fatty acid oxidation (GO:0019395) | 2.48070691 |
| 158 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 2.47168400 |
| 159 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.46962031 |
| 160 | tryptophan metabolic process (GO:0006568) | 2.46470631 |
| 161 | negative regulation of protein autophosphorylation (GO:0031953) | 2.45168306 |
| 162 | fibrinolysis (GO:0042730) | 2.44762500 |
| 163 | nitrogen cycle metabolic process (GO:0071941) | 2.44349598 |
| 164 | cell-matrix adhesion (GO:0007160) | 2.44302873 |
| 165 | platelet degranulation (GO:0002576) | 2.43895524 |
| 166 | 2-oxoglutarate metabolic process (GO:0006103) | 2.43696546 |
| 167 | negative regulation of cholesterol transport (GO:0032375) | 2.43619105 |
| 168 | negative regulation of sterol transport (GO:0032372) | 2.43619105 |
| 169 | cell-substrate adhesion (GO:0031589) | 2.43036061 |
| 170 | negative regulation of lipase activity (GO:0060192) | 2.42566917 |
| 171 | lipid oxidation (GO:0034440) | 2.42450531 |
| 172 | regulation of bile acid biosynthetic process (GO:0070857) | 2.41665150 |
| 173 | artery morphogenesis (GO:0048844) | 2.41525918 |
| 174 | drug metabolic process (GO:0017144) | 2.41476897 |
| 175 | cellular response to growth hormone stimulus (GO:0071378) | 2.41054186 |
| 176 | response to parathyroid hormone (GO:0071107) | 2.40799519 |
| 177 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.40355000 |
| 178 | protein-lipid complex remodeling (GO:0034368) | 2.40093795 |
| 179 | macromolecular complex remodeling (GO:0034367) | 2.40093795 |
| 180 | plasma lipoprotein particle remodeling (GO:0034369) | 2.40093795 |
| 181 | lipoprotein metabolic process (GO:0042157) | 2.39940821 |
| 182 | positive regulation of p38MAPK cascade (GO:1900745) | 2.39319063 |
| 183 | regulation of plasminogen activation (GO:0010755) | 2.39107652 |
| 184 | axon extension involved in axon guidance (GO:0048846) | 2.38665554 |
| 185 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.38665554 |
| 186 | carnitine shuttle (GO:0006853) | 2.38566056 |
| 187 | keratan sulfate catabolic process (GO:0042340) | 2.38471805 |
| 188 | hyaluronan catabolic process (GO:0030214) | 2.38402701 |
| 189 | anterior/posterior axis specification, embryo (GO:0008595) | 2.37800930 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.41249991 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.37098976 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.01775587 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.56106081 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.45907044 |
| 6 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.23644038 |
| 7 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.22246020 |
| 8 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.17459765 |
| 9 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.54432262 |
| 10 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.43897669 |
| 11 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.42095805 |
| 12 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.32783970 |
| 13 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.32756535 |
| 14 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.18117692 |
| 15 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.12543650 |
| 16 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.10424750 |
| 17 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.05887882 |
| 18 | TP53_16413492_ChIP-PET_HCT116_Human | 1.98099761 |
| 19 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.93254048 |
| 20 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.91652410 |
| 21 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.88984435 |
| 22 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.77629012 |
| 23 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.76778665 |
| 24 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.72795292 |
| 25 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.68872529 |
| 26 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.68522870 |
| 27 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.67055094 |
| 28 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.64521279 |
| 29 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.63687354 |
| 30 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.58451350 |
| 31 | * WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.58410821 |
| 32 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.58035470 |
| 33 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.56796581 |
| 34 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.49203063 |
| 35 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.47596994 |
| 36 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.44920009 |
| 37 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.43688824 |
| 38 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.42691235 |
| 39 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.41793902 |
| 40 | CJUN_26792858_Chip-Seq_BT549_Human | 1.41336923 |
| 41 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.41274606 |
| 42 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.40934332 |
| 43 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.39412978 |
| 44 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.38827164 |
| 45 | GATA1_22025678_ChIP-Seq_K562_Human | 1.37094941 |
| 46 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.37079506 |
| 47 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.32321814 |
| 48 | * GBX2_23144817_ChIP-Seq_PC3_Human | 1.30984095 |
| 49 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.30209264 |
| 50 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.29076736 |
| 51 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.28866737 |
| 52 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.27879015 |
| 53 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.27013691 |
| 54 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.27013691 |
| 55 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.25861979 |
| 56 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.25482158 |
| 57 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.22972094 |
| 58 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.22699547 |
| 59 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.22387648 |
| 60 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.22317989 |
| 61 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.21994125 |
| 62 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.20739187 |
| 63 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.20739187 |
| 64 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.19806525 |
| 65 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.17352059 |
| 66 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.13834004 |
| 67 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.12835540 |
| 68 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12700603 |
| 69 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.11372498 |
| 70 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.10041695 |
| 71 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.09859910 |
| 72 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.09465113 |
| 73 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.08277682 |
| 74 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.07724509 |
| 75 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.07540786 |
| 76 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.06801828 |
| 77 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.05130572 |
| 78 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.04890831 |
| 79 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.04790630 |
| 80 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.03809690 |
| 81 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.03034003 |
| 82 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.02714558 |
| 83 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.02184380 |
| 84 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.01339076 |
| 85 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.01221132 |
| 86 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.99958402 |
| 87 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.99755212 |
| 88 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.98961370 |
| 89 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.98658731 |
| 90 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.98123594 |
| 91 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.97780819 |
| 92 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.97703326 |
| 93 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.96989356 |
| 94 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.96956476 |
| 95 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.95986807 |
| 96 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.94684193 |
| 97 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.94507608 |
| 98 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.94458915 |
| 99 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 0.93805537 |
| 100 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.93020593 |
| 101 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.92799511 |
| 102 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.92239875 |
| 103 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.91626776 |
| 104 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.90566831 |
| 105 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.90429476 |
| 106 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.90179902 |
| 107 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.89709166 |
| 108 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.89504342 |
| 109 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.89504342 |
| 110 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.88659719 |
| 111 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.88001662 |
| 112 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.87565994 |
| 113 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.87309852 |
| 114 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.86950084 |
| 115 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.86875368 |
| 116 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.86756583 |
| 117 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.86348417 |
| 118 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.85854737 |
| 119 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.85670902 |
| 120 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.85670902 |
| 121 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.85206017 |
| 122 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.85112603 |
| 123 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.84961798 |
| 124 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.83796599 |
| 125 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.83618836 |
| 126 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.82979954 |
| 127 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.82398758 |
| 128 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.82277662 |
| 129 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.81269757 |
| 130 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.80807756 |
| 131 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.79691065 |
| 132 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.77750578 |
| 133 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 0.76974164 |
| 134 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.76906118 |
| 135 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.76681324 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 4.08050133 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 3.86620055 |
| 3 | MP0008438_abnormal_cutaneous_collagen | 3.71731274 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 3.31311509 |
| 5 | MP0005365_abnormal_bile_salt | 3.01650860 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 2.83535673 |
| 7 | MP0004272_abnormal_basement_membrane | 2.74304004 |
| 8 | MP0003252_abnormal_bile_duct | 2.66408298 |
| 9 | MP0003950_abnormal_plasma_membrane | 2.65611565 |
| 10 | MP0005275_abnormal_skin_tensile | 2.62098780 |
| 11 | MP0005257_abnormal_intraocular_pressure | 2.52333583 |
| 12 | MP0010368_abnormal_lymphatic_system | 2.51738160 |
| 13 | MP0003705_abnormal_hypodermis_morpholog | 2.49060012 |
| 14 | MP0001958_emphysema | 2.31426583 |
| 15 | MP0000516_abnormal_urinary_system | 2.24822272 |
| 16 | MP0005367_renal/urinary_system_phenotyp | 2.24822272 |
| 17 | MP0010329_abnormal_lipoprotein_level | 2.16438536 |
| 18 | MP0009384_cardiac_valve_regurgitation | 1.98865198 |
| 19 | MP0001879_abnormal_lymphatic_vessel | 1.95819720 |
| 20 | MP0001666_abnormal_nutrient_absorption | 1.90286231 |
| 21 | MP0005503_abnormal_tendon_morphology | 1.89757021 |
| 22 | MP0005508_abnormal_skeleton_morphology | 1.84690188 |
| 23 | MP0000462_abnormal_digestive_system | 1.84688371 |
| 24 | MP0006054_spinal_hemorrhage | 1.80083098 |
| 25 | MP0010234_abnormal_vibrissa_follicle | 1.76124703 |
| 26 | MP0003191_abnormal_cellular_cholesterol | 1.74796439 |
| 27 | MP0005332_abnormal_amino_acid | 1.68402630 |
| 28 | MP0000537_abnormal_urethra_morphology | 1.65821675 |
| 29 | * MP0001756_abnormal_urination | 1.61629298 |
| 30 | MP0002254_reproductive_system_inflammat | 1.56570243 |
| 31 | MP0000534_abnormal_ureter_morphology | 1.55967954 |
| 32 | MP0003941_abnormal_skin_development | 1.54461472 |
| 33 | MP0004019_abnormal_vitamin_homeostasis | 1.54031603 |
| 34 | MP0003300_gastrointestinal_ulcer | 1.47030341 |
| 35 | MP0000013_abnormal_adipose_tissue | 1.45413816 |
| 36 | MP0001299_abnormal_eye_distance/ | 1.45217028 |
| 37 | MP0004130_abnormal_muscle_cell | 1.42622770 |
| 38 | MP0009643_abnormal_urine_homeostasis | 1.42022388 |
| 39 | MP0005167_abnormal_blood-brain_barrier | 1.40747312 |
| 40 | MP0003279_aneurysm | 1.40382815 |
| 41 | MP0003566_abnormal_cell_adhesion | 1.36289150 |
| 42 | MP0000538_abnormal_urinary_bladder | 1.33985348 |
| 43 | MP0001661_extended_life_span | 1.31547710 |
| 44 | MP0005666_abnormal_adipose_tissue | 1.30120216 |
| 45 | MP0004185_abnormal_adipocyte_glucose | 1.29434893 |
| 46 | * MP0000230_abnormal_systemic_arterial | 1.26960264 |
| 47 | MP0000767_abnormal_smooth_muscle | 1.26688536 |
| 48 | MP0005319_abnormal_enzyme/_coenzyme | 1.26570775 |
| 49 | MP0002837_dystrophic_cardiac_calcinosis | 1.26074065 |
| 50 | MP0002138_abnormal_hepatobiliary_system | 1.25723414 |
| 51 | MP0004147_increased_porphyrin_level | 1.25627142 |
| 52 | MP0008004_abnormal_stomach_pH | 1.25595876 |
| 53 | MP0002118_abnormal_lipid_homeostasis | 1.25562691 |
| 54 | MP0003011_delayed_dark_adaptation | 1.25010644 |
| 55 | MP0009250_abnormal_appendicular_skeleto | 1.24972591 |
| 56 | MP0000751_myopathy | 1.21959835 |
| 57 | MP0005670_abnormal_white_adipose | 1.19028186 |
| 58 | MP0003045_fibrosis | 1.16686516 |
| 59 | MP0002295_abnormal_pulmonary_circulatio | 1.16022395 |
| 60 | MP0006138_congestive_heart_failure | 1.16020765 |
| 61 | MP0005390_skeleton_phenotype | 1.14003861 |
| 62 | MP0004084_abnormal_cardiac_muscle | 1.13840185 |
| 63 | MP0001243_abnormal_dermal_layer | 1.13245836 |
| 64 | MP0002166_altered_tumor_susceptibility | 1.13229735 |
| 65 | MP0005375_adipose_tissue_phenotype | 1.11537491 |
| 66 | MP0001348_abnormal_lacrimal_gland | 1.11333879 |
| 67 | MP0000609_abnormal_liver_physiology | 1.09941817 |
| 68 | MP0005330_cardiomyopathy | 1.08384872 |
| 69 | MP0010030_abnormal_orbit_morphology | 1.05797414 |
| 70 | MP0005623_abnormal_meninges_morphology | 1.04068607 |
| 71 | MP0005164_abnormal_response_to | 1.03255138 |
| 72 | MP0003283_abnormal_digestive_organ | 1.03156087 |
| 73 | * MP0001664_abnormal_digestion | 1.01168215 |
| 74 | MP0000003_abnormal_adipose_tissue | 1.01067614 |
| 75 | MP0002136_abnormal_kidney_physiology | 0.99767382 |
| 76 | MP0003195_calcinosis | 0.99351250 |
| 77 | MP0000428_abnormal_craniofacial_morphol | 0.99340531 |
| 78 | MP0001849_ear_inflammation | 0.98648351 |
| 79 | MP0009840_abnormal_foam_cell | 0.97835982 |
| 80 | MP0002115_abnormal_skeleton_extremities | 0.96958944 |
| 81 | MP0005023_abnormal_wound_healing | 0.96633944 |
| 82 | MP0002060_abnormal_skin_morphology | 0.95998316 |
| 83 | MP0005595_abnormal_vascular_smooth | 0.94543967 |
| 84 | MP0002877_abnormal_melanocyte_morpholog | 0.94411249 |
| 85 | MP0000163_abnormal_cartilage_morphology | 0.92407771 |
| 86 | MP0000733_abnormal_muscle_development | 0.92265003 |
| 87 | MP0005647_abnormal_sex_gland | 0.91932598 |
| 88 | MP0005464_abnormal_platelet_physiology | 0.89646082 |
| 89 | MP0002168_other_aberrant_phenotype | 0.88457369 |
| 90 | MP0001765_abnormal_ion_homeostasis | 0.87985134 |
| 91 | MP0004858_abnormal_nervous_system | 0.86917107 |
| 92 | MP0002998_abnormal_bone_remodeling | 0.86352886 |
| 93 | MP0000762_abnormal_tongue_morphology | 0.85974941 |
| 94 | MP0004134_abnormal_chest_morphology | 0.85918341 |
| 95 | * MP0005620_abnormal_muscle_contractility | 0.85143276 |
| 96 | MP0002135_abnormal_kidney_morphology | 0.84277928 |
| 97 | MP0009053_abnormal_anal_canal | 0.83569033 |
| 98 | MP0005388_respiratory_system_phenotype | 0.83315735 |
| 99 | MP0002133_abnormal_respiratory_system | 0.83315735 |
| 100 | MP0000249_abnormal_blood_vessel | 0.82667051 |
| 101 | MP0001542_abnormal_bone_strength | 0.81879844 |
| 102 | MP0003115_abnormal_respiratory_system | 0.80331396 |
| 103 | MP0003868_abnormal_feces_composition | 0.79802533 |
| 104 | MP0002128_abnormal_blood_circulation | 0.79688745 |
| 105 | MP0004883_abnormal_blood_vessel | 0.79601607 |
| 106 | MP0002108_abnormal_muscle_morphology | 0.78497029 |
| 107 | MP0005171_absent_coat_pigmentation | 0.78260408 |
| 108 | MP0005083_abnormal_biliary_tract | 0.77899541 |
| 109 | MP0000749_muscle_degeneration | 0.77764268 |
| 110 | MP0002933_joint_inflammation | 0.77743989 |
| 111 | MP0003091_abnormal_cell_migration | 0.77581592 |
| 112 | MP0003828_pulmonary_edema | 0.76670330 |
| 113 | MP0005409_darkened_coat_color | 0.76269546 |
| 114 | MP0009764_decreased_sensitivity_to | 0.75818380 |
| 115 | MP0005187_abnormal_penis_morphology | 0.75355691 |
| 116 | MP0002896_abnormal_bone_mineralization | 0.73263282 |
| 117 | MP0002009_preneoplasia | 0.72750841 |
| 118 | * MP0004036_abnormal_muscle_relaxation | 0.72338117 |
| 119 | MP0001614_abnormal_blood_vessel | 0.70693169 |
| 120 | MP0001533_abnormal_skeleton_physiology | 0.70503867 |
| 121 | MP0000432_abnormal_head_morphology | 0.70374153 |
| 122 | MP0002282_abnormal_trachea_morphology | 0.69685687 |
| 123 | MP0005636_abnormal_mineral_homeostasis | 0.69421204 |
| 124 | MP0003942_abnormal_urinary_system | 0.69293237 |
| 125 | MP0001881_abnormal_mammary_gland | 0.69119379 |
| 126 | MP0009780_abnormal_chondrocyte_physiolo | 0.68359109 |
| 127 | MP0005197_abnormal_uvea_morphology | 0.67890314 |
| 128 | MP0001175_abnormal_lung_morphology | 0.67744735 |
| 129 | MP0001544_abnormal_cardiovascular_syste | 0.67055143 |
| 130 | MP0005385_cardiovascular_system_phenoty | 0.67055143 |
| 131 | MP0004264_abnormal_extraembryonic_tissu | 0.66882408 |
| 132 | MP0002113_abnormal_skeleton_development | 0.66493368 |
| 133 | MP0003385_abnormal_body_wall | 0.65866173 |
| 134 | MP0002925_abnormal_cardiovascular_devel | 0.65177435 |
| 135 | MP0010352_gastrointestinal_tract_polyps | 0.64222877 |
| 136 | MP0003724_increased_susceptibility_to | 0.63413443 |
| 137 | MP0005165_increased_susceptibility_to | 0.62708463 |
| 138 | MP0000759_abnormal_skeletal_muscle | 0.62179915 |
| 139 | MP0008775_abnormal_heart_ventricle | 0.62062158 |
| 140 | MP0003795_abnormal_bone_structure | 0.61159839 |
| 141 | MP0003448_altered_tumor_morphology | 0.59108153 |
| 142 | * MP0010386_abnormal_urinary_bladder | 0.56377427 |
| 143 | MP0005193_abnormal_anterior_eye | 0.55645616 |
| 144 | MP0004510_myositis | 0.55457934 |
| 145 | MP0001915_intracranial_hemorrhage | 0.54320112 |
| 146 | MP0004087_abnormal_muscle_fiber | 0.53819640 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Aortic aneurysm (HP:0004942) | 5.59513689 |
| 2 | * Aortic dissection (HP:0002647) | 4.80776299 |
| 3 | Facial diplegia (HP:0001349) | 4.74650211 |
| 4 | Papilledema (HP:0001085) | 4.62024404 |
| 5 | Ankle contracture (HP:0006466) | 4.29947911 |
| 6 | Vascular tortuosity (HP:0004948) | 4.21164966 |
| 7 | Deep venous thrombosis (HP:0002625) | 4.01330130 |
| 8 | Soft skin (HP:0000977) | 3.85116819 |
| 9 | Increased density of long bones (HP:0006392) | 3.83027098 |
| 10 | Malnutrition (HP:0004395) | 3.78196540 |
| 11 | Arterial tortuosity (HP:0005116) | 3.67479156 |
| 12 | Cerebral aneurysm (HP:0004944) | 3.64655202 |
| 13 | Complement deficiency (HP:0004431) | 3.64345834 |
| 14 | Neonatal short-limb short stature (HP:0008921) | 3.63299122 |
| 15 | Broad metatarsal (HP:0001783) | 3.59364863 |
| 16 | Bladder diverticulum (HP:0000015) | 3.54576045 |
| 17 | Cervical subluxation (HP:0003308) | 3.47789007 |
| 18 | Wormian bones (HP:0002645) | 3.46348165 |
| 19 | Shallow orbits (HP:0000586) | 3.30313760 |
| 20 | Type 1 muscle fiber predominance (HP:0003803) | 3.29244877 |
| 21 | Mesangial abnormality (HP:0001966) | 3.11888814 |
| 22 | Intrahepatic cholestasis (HP:0001406) | 3.06932602 |
| 23 | Aortic regurgitation (HP:0001659) | 3.06307705 |
| 24 | Fragile skin (HP:0001030) | 3.03685454 |
| 25 | Gastrointestinal dysmotility (HP:0002579) | 3.00739269 |
| 26 | Abnormality of dentin (HP:0010299) | 2.99268881 |
| 27 | Spondylolisthesis (HP:0003302) | 2.98033054 |
| 28 | Long toe (HP:0010511) | 2.97728571 |
| 29 | Xanthomatosis (HP:0000991) | 2.89700836 |
| 30 | Protrusio acetabuli (HP:0003179) | 2.87450250 |
| 31 | Blue sclerae (HP:0000592) | 2.86753859 |
| 32 | Wide anterior fontanel (HP:0000260) | 2.86321629 |
| 33 | Right ventricular cardiomyopathy (HP:0011663) | 2.86166699 |
| 34 | Slender build (HP:0001533) | 2.83511815 |
| 35 | Focal segmental glomerulosclerosis (HP:0000097) | 2.78200374 |
| 36 | * Aneurysm (HP:0002617) | 2.76630742 |
| 37 | Peritonitis (HP:0002586) | 2.75932555 |
| 38 | Genu recurvatum (HP:0002816) | 2.69826126 |
| 39 | Neoplasm of the heart (HP:0100544) | 2.66749177 |
| 40 | Ulnar bowing (HP:0003031) | 2.65965451 |
| 41 | Joint laxity (HP:0001388) | 2.60909826 |
| 42 | Nephritis (HP:0000123) | 2.57110475 |
| 43 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.56984378 |
| 44 | Osteolytic defects of the hand bones (HP:0009699) | 2.56984378 |
| 45 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.56580113 |
| 46 | Stroke (HP:0001297) | 2.56069369 |
| 47 | Rectal prolapse (HP:0002035) | 2.54321605 |
| 48 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.53439676 |
| 49 | Abnormality of complement system (HP:0005339) | 2.50532159 |
| 50 | Hypoventilation (HP:0002791) | 2.49328636 |
| 51 | Short hallux (HP:0010109) | 2.49087889 |
| 52 | Vertebral compression fractures (HP:0002953) | 2.45919943 |
| 53 | Increased connective tissue (HP:0009025) | 2.45441513 |
| 54 | Pigmentary retinal degeneration (HP:0001146) | 2.45207680 |
| 55 | Mitral regurgitation (HP:0001653) | 2.45041873 |
| 56 | Wrist flexion contracture (HP:0001239) | 2.40204462 |
| 57 | Mitral stenosis (HP:0001718) | 2.39555195 |
| 58 | Mitral valve prolapse (HP:0001634) | 2.39417666 |
| 59 | Abnormal platelet volume (HP:0011876) | 2.38524223 |
| 60 | Facial shape deformation (HP:0011334) | 2.37919889 |
| 61 | Potter facies (HP:0002009) | 2.37919889 |
| 62 | Lymphangioma (HP:0100764) | 2.37915288 |
| 63 | Bicuspid aortic valve (HP:0001647) | 2.37107646 |
| 64 | Bowel diverticulosis (HP:0005222) | 2.36894754 |
| 65 | Elbow flexion contracture (HP:0002987) | 2.36571518 |
| 66 | Biconcave vertebral bodies (HP:0004586) | 2.35165084 |
| 67 | Hyperextensible skin (HP:0000974) | 2.32994895 |
| 68 | Absent frontal sinuses (HP:0002688) | 2.32609892 |
| 69 | Premature rupture of membranes (HP:0001788) | 2.32393978 |
| 70 | Glomerulosclerosis (HP:0000096) | 2.31619756 |
| 71 | Cardiovascular calcification (HP:0011915) | 2.30836351 |
| 72 | Mesomelia (HP:0003027) | 2.29813568 |
| 73 | Camptodactyly of toe (HP:0001836) | 2.29386770 |
| 74 | Coronal craniosynostosis (HP:0004440) | 2.29339627 |
| 75 | Esophageal varix (HP:0002040) | 2.28355504 |
| 76 | Increased variability in muscle fiber diameter (HP:0003557) | 2.27365221 |
| 77 | Hyperlipoproteinemia (HP:0010980) | 2.24834377 |
| 78 | Follicular hyperkeratosis (HP:0007502) | 2.24703064 |
| 79 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.23038952 |
| 80 | Polycythemia (HP:0001901) | 2.22127497 |
| 81 | Mild short stature (HP:0003502) | 2.22007882 |
| 82 | Abnormality of the common coagulation pathway (HP:0010990) | 2.21500648 |
| 83 | Overgrowth (HP:0001548) | 2.21281585 |
| 84 | Myocardial infarction (HP:0001658) | 2.20865585 |
| 85 | Hypoalphalipoproteinemia (HP:0003233) | 2.19894960 |
| 86 | Hyperglycinuria (HP:0003108) | 2.19709532 |
| 87 | Abnormal delivery (HP:0001787) | 2.19217983 |
| 88 | Spinal rigidity (HP:0003306) | 2.18910707 |
| 89 | Abnormality of the acetabulum (HP:0003170) | 2.17927139 |
| 90 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.17068034 |
| 91 | Spastic diplegia (HP:0001264) | 2.13873311 |
| 92 | Hematochezia (HP:0002573) | 2.12827176 |
| 93 | Aortic valve stenosis (HP:0001650) | 2.12797523 |
| 94 | Hypobetalipoproteinemia (HP:0003563) | 2.10600133 |
| 95 | Prolonged partial thromboplastin time (HP:0003645) | 2.10568246 |
| 96 | Vascular calcification (HP:0004934) | 2.10454187 |
| 97 | Abnormal foot bone ossification (HP:0010675) | 2.09836699 |
| 98 | Broad ribs (HP:0000885) | 2.08993008 |
| 99 | Menorrhagia (HP:0000132) | 2.08686839 |
| 100 | Dilatation of the ascending aorta (HP:0005111) | 2.08683785 |
| 101 | Glomerulonephritis (HP:0000099) | 2.07631260 |
| 102 | Abnormality of the intrinsic pathway (HP:0010989) | 2.07542312 |
| 103 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.07223654 |
| 104 | Limited hip movement (HP:0008800) | 2.06079084 |
| 105 | Epidermoid cyst (HP:0200040) | 2.05132678 |
| 106 | Hypoplasia of the iris (HP:0007676) | 2.04193448 |
| 107 | Hypolipoproteinemia (HP:0010981) | 2.02742689 |
| 108 | Hydroureter (HP:0000072) | 2.00895982 |
| 109 | Shawl scrotum (HP:0000049) | 2.00824770 |
| 110 | Short 4th metacarpal (HP:0010044) | 1.99567597 |
| 111 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.99567597 |
| 112 | Visceral angiomatosis (HP:0100761) | 1.98351815 |
| 113 | Natal tooth (HP:0000695) | 1.97467992 |
| 114 | Abnormal cartilage morphology (HP:0002763) | 1.97322402 |
| 115 | Hip contracture (HP:0003273) | 1.96184090 |
| 116 | Spontaneous abortion (HP:0005268) | 1.96087135 |
| 117 | Knee flexion contracture (HP:0006380) | 1.95738617 |
| 118 | Hemorrhage of the eye (HP:0011885) | 1.95694129 |
| 119 | Abnormality of proline metabolism (HP:0010907) | 1.95662233 |
| 120 | Hydroxyprolinuria (HP:0003080) | 1.95662233 |
| 121 | Broad face (HP:0000283) | 1.95555514 |
| 122 | Abnormality of the 4th metacarpal (HP:0010012) | 1.95166176 |
| 123 | Stridor (HP:0010307) | 1.95115729 |
| 124 | Hyperammonemia (HP:0001987) | 1.95044063 |
| 125 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.93478627 |
| 126 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.92275123 |
| 127 | Radial bowing (HP:0002986) | 1.91211079 |
| 128 | Short nail (HP:0001799) | 1.89834425 |
| 129 | Scapular winging (HP:0003691) | 1.89662866 |
| 130 | Ectopia lentis (HP:0001083) | 1.89078134 |
| 131 | Hyporeflexia of lower limbs (HP:0002600) | 1.88630105 |
| 132 | Pulmonary artery stenosis (HP:0004415) | 1.88169199 |
| 133 | Fat malabsorption (HP:0002630) | 1.87511699 |
| 134 | Ileus (HP:0002595) | 1.86450786 |
| 135 | Atrophic scars (HP:0001075) | 1.85326455 |
| 136 | Back pain (HP:0003418) | 1.85083259 |
| 137 | Ketosis (HP:0001946) | 1.85082089 |
| 138 | Joint stiffness (HP:0001387) | 1.84911302 |
| 139 | Increased mean platelet volume (HP:0011877) | 1.84630449 |
| 140 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.84479167 |
| 141 | Hemangiomatosis (HP:0007461) | 1.83793878 |
| 142 | Round ear (HP:0100830) | 1.83550373 |
| 143 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.83337881 |
| 144 | Abnormal ossification of hand bones (HP:0005921) | 1.82877027 |
| 145 | Spinal cord lesions (HP:0100561) | 1.82869047 |
| 146 | Syringomyelia (HP:0003396) | 1.82869047 |
| 147 | Skin nodule (HP:0200036) | 1.81896500 |
| 148 | Persistence of primary teeth (HP:0006335) | 1.81863472 |
| 149 | Bowed forearm bones (HP:0003956) | 1.81244842 |
| 150 | Bowing of the arm (HP:0006488) | 1.81244842 |
| 151 | Delayed closure of the anterior fontanelle (HP:0001476) | 1.78910023 |
| 152 | Striae distensae (HP:0001065) | 1.76620967 |
| 153 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.74311402 |
| 154 | Short clavicles (HP:0000894) | 1.73891977 |
| 155 | Osteoarthritis (HP:0002758) | 1.72393795 |
| 156 | Infantile muscular hypotonia (HP:0008947) | 1.72197614 |
| 157 | Flared iliac wings (HP:0002869) | 1.71041900 |
| 158 | Bradycardia (HP:0001662) | 1.70025778 |
| 159 | Delayed cranial suture closure (HP:0000270) | 1.69935614 |
| 160 | Thoracolumbar scoliosis (HP:0002944) | 1.69932220 |
| 161 | Abnormality of skull ossification (HP:0002703) | 1.69208785 |
| 162 | Abnormality of carpal bone ossification (HP:0006257) | 1.67943527 |
| 163 | Arachnodactyly (HP:0001166) | 1.67599463 |
| 164 | Disproportionate tall stature (HP:0001519) | 1.67383627 |
| 165 | Protruding ear (HP:0000411) | 1.66684521 |
| 166 | Tibial bowing (HP:0002982) | 1.66238394 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 5.03252751 |
| 2 | * MYLK | 3.45107398 |
| 3 | DMPK | 3.40300241 |
| 4 | ERN1 | 2.85022713 |
| 5 | TIE1 | 2.63173925 |
| 6 | FRK | 2.60920042 |
| 7 | TRIB3 | 2.55628072 |
| 8 | SIK1 | 2.53739547 |
| 9 | PIK3CG | 2.53563727 |
| 10 | LATS1 | 2.51195622 |
| 11 | TGFBR2 | 2.37663377 |
| 12 | EPHB2 | 2.36021904 |
| 13 | AKT3 | 2.25171562 |
| 14 | PDGFRA | 2.23383202 |
| 15 | LMTK2 | 2.22822482 |
| 16 | RIPK1 | 2.15081002 |
| 17 | MST1R | 1.92849994 |
| 18 | DDR2 | 1.90910428 |
| 19 | TRPM7 | 1.89447563 |
| 20 | NUAK1 | 1.86759822 |
| 21 | LIMK1 | 1.80108643 |
| 22 | PIK3CA | 1.79239870 |
| 23 | BCKDK | 1.75595124 |
| 24 | NTRK1 | 1.75499117 |
| 25 | PRKD2 | 1.66614970 |
| 26 | PTK6 | 1.65368966 |
| 27 | STK38 | 1.62441905 |
| 28 | FGFR4 | 1.60593640 |
| 29 | FGFR2 | 1.47998399 |
| 30 | CAMK1D | 1.44390290 |
| 31 | FER | 1.43825334 |
| 32 | MET | 1.34750447 |
| 33 | WNK4 | 1.32655332 |
| 34 | EPHA3 | 1.23833051 |
| 35 | KDR | 1.21750990 |
| 36 | ADRBK1 | 1.20357257 |
| 37 | GRK7 | 1.20162122 |
| 38 | PTK2B | 1.18672774 |
| 39 | STK39 | 1.18479649 |
| 40 | PKN2 | 1.18372854 |
| 41 | ROCK1 | 1.14436533 |
| 42 | CAMK1G | 1.11232295 |
| 43 | TAOK3 | 1.10556181 |
| 44 | KIT | 1.09364999 |
| 45 | EPHB1 | 1.07858143 |
| 46 | * PAK2 | 1.04147179 |
| 47 | PTK2 | 1.01028760 |
| 48 | MAP3K6 | 0.99153595 |
| 49 | PDK2 | 0.96511533 |
| 50 | CDC42BPA | 0.95855326 |
| 51 | STK38L | 0.92925256 |
| 52 | GRK1 | 0.89522829 |
| 53 | INSRR | 0.87431011 |
| 54 | PDGFRB | 0.87399700 |
| 55 | MAPK7 | 0.87011823 |
| 56 | GRK5 | 0.84015931 |
| 57 | LRRK2 | 0.79952630 |
| 58 | MELK | 0.79926171 |
| 59 | EEF2K | 0.79646042 |
| 60 | TGFBR1 | 0.77785064 |
| 61 | TESK1 | 0.75601787 |
| 62 | DAPK3 | 0.75430492 |
| 63 | PAK3 | 0.75090421 |
| 64 | MST4 | 0.74164625 |
| 65 | PRKAA2 | 0.72686512 |
| 66 | MAP3K7 | 0.72106908 |
| 67 | FGFR3 | 0.70305311 |
| 68 | MAPKAPK3 | 0.70244088 |
| 69 | MAP3K2 | 0.69504797 |
| 70 | ERBB4 | 0.68240564 |
| 71 | JAK1 | 0.67218915 |
| 72 | MARK2 | 0.66670744 |
| 73 | MAP3K3 | 0.66138140 |
| 74 | PAK4 | 0.65786524 |
| 75 | ILK | 0.65484273 |
| 76 | STK3 | 0.65465467 |
| 77 | PRKG2 | 0.64294214 |
| 78 | RPS6KA2 | 0.62393001 |
| 79 | CDK12 | 0.61425658 |
| 80 | MAP2K1 | 0.60725744 |
| 81 | NEK9 | 0.60127566 |
| 82 | OXSR1 | 0.59735566 |
| 83 | CAMK1 | 0.59342771 |
| 84 | RET | 0.58830331 |
| 85 | NLK | 0.57562511 |
| 86 | LATS2 | 0.56011610 |
| 87 | MTOR | 0.53066278 |
| 88 | ZAP70 | 0.50903190 |
| 89 | TYK2 | 0.50371400 |
| 90 | BMX | 0.49924609 |
| 91 | PDK4 | 0.49709197 |
| 92 | PDK3 | 0.49709197 |
| 93 | JAK2 | 0.49418604 |
| 94 | PRKCE | 0.47390321 |
| 95 | SGK3 | 0.46578024 |
| 96 | PRKD1 | 0.46464405 |
| 97 | MAP2K3 | 0.44986250 |
| 98 | FLT3 | 0.43210123 |
| 99 | MAP2K2 | 0.42909111 |
| 100 | PAK6 | 0.42357931 |
| 101 | MAPK12 | 0.41393447 |
| 102 | ERBB2 | 0.40348678 |
| 103 | HIPK2 | 0.39755273 |
| 104 | RPS6KA6 | 0.38846330 |
| 105 | ICK | 0.38788194 |
| 106 | MAP3K10 | 0.37455737 |
| 107 | PRKCH | 0.37388025 |
| 108 | PDPK1 | 0.37175843 |
| 109 | EPHA2 | 0.36046303 |
| 110 | MAP2K4 | 0.35575868 |
| 111 | CSK | 0.35552564 |
| 112 | PRKAA1 | 0.35288136 |
| 113 | * PAK1 | 0.35234647 |
| 114 | CDK8 | 0.34721341 |
| 115 | * SRC | 0.33007892 |
| 116 | FGFR1 | 0.32949174 |
| 117 | ADRBK2 | 0.32441638 |
| 118 | IGF1R | 0.32387541 |
| 119 | MAPK11 | 0.32256069 |
| 120 | CAMK2B | 0.31184608 |
| 121 | MOS | 0.30832854 |
| 122 | CAMK2D | 0.30277164 |
| 123 | PRKG1 | 0.30208895 |
| 124 | INSR | 0.29998815 |
| 125 | FYN | 0.29621660 |
| 126 | ABL2 | 0.29240572 |
| 127 | WNK1 | 0.28799008 |
| 128 | RPS6KC1 | 0.27998203 |
| 129 | RPS6KL1 | 0.27998203 |
| 130 | * GSK3A | 0.27863594 |
| 131 | SGK2 | 0.27206313 |
| 132 | TBK1 | 0.27016374 |
| 133 | ROCK2 | 0.26984701 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.98448497 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.76557327 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.64562178 |
| 4 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.53373977 |
| 5 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.38226780 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.25602524 |
| 7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.25320745 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.16039274 |
| 9 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.09371730 |
| 10 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.08002653 |
| 11 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.07724443 |
| 12 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.01122652 |
| 13 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.93221093 |
| 14 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.92999176 |
| 15 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.90703255 |
| 16 | Bile secretion_Homo sapiens_hsa04976 | 1.89101194 |
| 17 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.87532031 |
| 18 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.81484434 |
| 19 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.76081281 |
| 20 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.72659972 |
| 21 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.72275900 |
| 22 | * Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.71150499 |
| 23 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.65325015 |
| 24 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.57635162 |
| 25 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.53503283 |
| 26 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.53381651 |
| 27 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.52606959 |
| 28 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.49021428 |
| 29 | Histidine metabolism_Homo sapiens_hsa00340 | 1.47624224 |
| 30 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.45188681 |
| 31 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.43031310 |
| 32 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.42643078 |
| 33 | ABC transporters_Homo sapiens_hsa02010 | 1.40766675 |
| 34 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.40474218 |
| 35 | Peroxisome_Homo sapiens_hsa04146 | 1.39559234 |
| 36 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.31882420 |
| 37 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.29310840 |
| 38 | * Focal adhesion_Homo sapiens_hsa04510 | 1.29273515 |
| 39 | Gap junction_Homo sapiens_hsa04540 | 1.28901818 |
| 40 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.26026037 |
| 41 | Melanoma_Homo sapiens_hsa05218 | 1.23760293 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.23693538 |
| 43 | Retinol metabolism_Homo sapiens_hsa00830 | 1.19969691 |
| 44 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.19313092 |
| 45 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.18507634 |
| 46 | * Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.11965512 |
| 47 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.11515279 |
| 48 | Malaria_Homo sapiens_hsa05144 | 1.08936719 |
| 49 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.06929158 |
| 50 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.06136563 |
| 51 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.05096439 |
| 52 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.02961911 |
| 53 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.02765253 |
| 54 | Amoebiasis_Homo sapiens_hsa05146 | 1.02735895 |
| 55 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.00908819 |
| 56 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.00479677 |
| 57 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.00275860 |
| 58 | Pathways in cancer_Homo sapiens_hsa05200 | 0.99069297 |
| 59 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.98986737 |
| 60 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.96280055 |
| 61 | Prostate cancer_Homo sapiens_hsa05215 | 0.94968365 |
| 62 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.94609655 |
| 63 | Lysine degradation_Homo sapiens_hsa00310 | 0.94392452 |
| 64 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.94305656 |
| 65 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.92851558 |
| 66 | Glioma_Homo sapiens_hsa05214 | 0.91278860 |
| 67 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.90097613 |
| 68 | Melanogenesis_Homo sapiens_hsa04916 | 0.88562877 |
| 69 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.88562086 |
| 70 | Insulin resistance_Homo sapiens_hsa04931 | 0.85822379 |
| 71 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.83294683 |
| 72 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.80728830 |
| 73 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.79109858 |
| 74 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.78097513 |
| 75 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.78013991 |
| 76 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.76730137 |
| 77 | Axon guidance_Homo sapiens_hsa04360 | 0.76440071 |
| 78 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.76283249 |
| 79 | Carbon metabolism_Homo sapiens_hsa01200 | 0.72950483 |
| 80 | * Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.71840247 |
| 81 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.71189544 |
| 82 | Mineral absorption_Homo sapiens_hsa04978 | 0.70139552 |
| 83 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.69970737 |
| 84 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.69633939 |
| 85 | Adherens junction_Homo sapiens_hsa04520 | 0.69338852 |
| 86 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.68719776 |
| 87 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.68609294 |
| 88 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.68424177 |
| 89 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.67749994 |
| 90 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.67341008 |
| 91 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.66848028 |
| 92 | * Calcium signaling pathway_Homo sapiens_hsa04020 | 0.66380954 |
| 93 | Endocytosis_Homo sapiens_hsa04144 | 0.65663614 |
| 94 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.65347099 |
| 95 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.65339028 |
| 96 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.64565079 |
| 97 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.63688741 |
| 98 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.63143829 |
| 99 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.63095210 |
| 100 | Tight junction_Homo sapiens_hsa04530 | 0.62670831 |
| 101 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.62526093 |
| 102 | Other glycan degradation_Homo sapiens_hsa00511 | 0.62448592 |
| 103 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.62386958 |
| 104 | Phototransduction_Homo sapiens_hsa04744 | 0.61454977 |
| 105 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.61363932 |
| 106 | Salivary secretion_Homo sapiens_hsa04970 | 0.61206760 |
| 107 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.60870137 |
| 108 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.60648570 |
| 109 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.60556628 |
| 110 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.60293665 |
| 111 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.58931127 |
| 112 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.58863383 |
| 113 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.58435298 |
| 114 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.58270582 |
| 115 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.57169124 |
| 116 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.56872199 |
| 117 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.56093649 |
| 118 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.55393499 |
| 119 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.55215587 |
| 120 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.55124462 |
| 121 | Cocaine addiction_Homo sapiens_hsa05030 | 0.54180421 |
| 122 | Pertussis_Homo sapiens_hsa05133 | 0.52329340 |
| 123 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.50480152 |
| 124 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.49826055 |
| 125 | Renin secretion_Homo sapiens_hsa04924 | 0.49529958 |
| 126 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.48795395 |
| 127 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.48416866 |
| 128 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.48396057 |
| 129 | Circadian rhythm_Homo sapiens_hsa04710 | 0.48384249 |
| 130 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.47781971 |
| 131 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.47461175 |
| 132 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.47251533 |
| 133 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.46419450 |
| 134 | Bladder cancer_Homo sapiens_hsa05219 | 0.45725441 |
| 135 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.45606105 |
| 136 | Circadian entrainment_Homo sapiens_hsa04713 | 0.45485038 |
| 137 | Shigellosis_Homo sapiens_hsa05131 | 0.45369204 |
| 138 | Long-term depression_Homo sapiens_hsa04730 | 0.45084645 |
| 139 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.44491646 |
| 140 | Insulin secretion_Homo sapiens_hsa04911 | 0.44430008 |
| 141 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.44324300 |
| 142 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.44111904 |
| 143 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.43936421 |
| 144 | Endometrial cancer_Homo sapiens_hsa05213 | 0.42421704 |
| 145 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.42295052 |
| 146 | * cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.41738032 |
| 147 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.37958994 |
| 148 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.36279509 |
| 149 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.36178586 |
| 150 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.34388960 |
| 151 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.34384207 |
| 152 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.34085033 |
| 153 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.32988342 |
| 154 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.29002412 |
| 155 | Prion diseases_Homo sapiens_hsa05020 | 0.27888346 |
| 156 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.26911416 |
| 157 | * Platelet activation_Homo sapiens_hsa04611 | 0.26259250 |
| 158 | Galactose metabolism_Homo sapiens_hsa00052 | 0.25998556 |
| 159 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.23847177 |
| 160 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.23042001 |
| 161 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.22106133 |
| 162 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.22024869 |

